Search research articles
Contact Us
Filters
Showing results (261-270 of 369) with videos related to
Page
of 37
Sort By:
European Journal of Histochemistry : EJH
|
February 3, 2012
Decreased apoptosis in fatty livers submitted to subnormothermic machine-perfusion respect to cold storage
E Boncompagni, E Gini, A Ferrigno, et al.
Oncology
|
May 1, 1995
A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates
S Barni, P Lissoni, M Cazzaniga, et al.
Tumori
|
June 30, 1991
Neuroendocrine effects of subcutaneous interleukin-2 injection in cancer patients
P Lissoni, S Barni, F Rovelli, et al.
Oncology
|
January 1, 1990
Pineal gland and tumor cell kinetics: serum levels of melatonin in relation to Ki-67 labeling rate in breast cancer
P Lissoni, S Crispino, S Barni, et al.
Recenti Progressi in Medicina
|
June 1, 1995
Prevention of interleukin-2-induced thrombocytopenia during the immunotherapy of cancer by a concomitant administration of the pineal hormone melatonin
E R Bregani, P Lissoni, F Rossini, et al.
British Journal of Cancer
|
August 14, 1998
Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, R Labianca, F Graziano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Postoperative hyperprolactinaemia and early recurrence rate in breast cancer
P Lissoni, A L Sormani, G Tancini, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1991
Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatonin
P Lissoni, E Tisi, F Brivio, et al.
Tumori
|
March 18, 1999
Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer
M Clerici, F De Marinis, E Piazza, et al.
British Journal of Cancer
|
November 1, 1991
Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2
P Lissoni, F Brivio, S Pittalis, et al.
Page
of 37
Search research articles
Search
Showing results (261-270 of 369) with videos related to
Sort By:
Page
of 37
European Journal of Histochemistry : EJH
|
February 3, 2012
Decreased apoptosis in fatty livers submitted to subnormothermic machine-perfusion respect to cold storage
E Boncompagni, E Gini, A Ferrigno, et al.
Oncology
|
May 1, 1995
A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates
S Barni, P Lissoni, M Cazzaniga, et al.
Tumori
|
June 30, 1991
Neuroendocrine effects of subcutaneous interleukin-2 injection in cancer patients
P Lissoni, S Barni, F Rovelli, et al.
Oncology
|
January 1, 1990
Pineal gland and tumor cell kinetics: serum levels of melatonin in relation to Ki-67 labeling rate in breast cancer
P Lissoni, S Crispino, S Barni, et al.
Recenti Progressi in Medicina
|
June 1, 1995
Prevention of interleukin-2-induced thrombocytopenia during the immunotherapy of cancer by a concomitant administration of the pineal hormone melatonin
E R Bregani, P Lissoni, F Rossini, et al.
British Journal of Cancer
|
August 14, 1998
Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, R Labianca, F Graziano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Postoperative hyperprolactinaemia and early recurrence rate in breast cancer
P Lissoni, A L Sormani, G Tancini, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1991
Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatonin
P Lissoni, E Tisi, F Brivio, et al.
Tumori
|
March 18, 1999
Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer
M Clerici, F De Marinis, E Piazza, et al.
British Journal of Cancer
|
November 1, 1991
Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2
P Lissoni, F Brivio, S Pittalis, et al.
Page
of 37